Roche Diagnostics
Visit Roche Booth #20005
• Learn more about the only FDA-approved companion diagnostic liquid biopsy for NSCLC -- cobas® EGFR Mutation Test v2, and see how innovative technologies such as NAVIFY® Mutation Profiler† and NAVIFY® Tumor Board can help clinicians make more confident patient treatment decisions. †In Development.
• Ask us about clinical research using AVENIO NGS assays* with matched liquid biopsy and tumor tissue panels for comprehensive genomic profiling, longitudinal monitoring of tumor burden and concordance analysis. *For Research Use Only. Not for use in diagnostic procedures.